scholarly article | Q13442814 |
P356 | DOI | 10.1136/BMJ.1.6013.812 |
P953 | full work available at URL | https://europepmc.org/articles/PMC1639412 |
https://europepmc.org/articles/PMC1639412?pdf=render | ||
P932 | PMC publication ID | 1639412 |
P698 | PubMed publication ID | 1260345 |
P2093 | author name string | T. J. John | |
P2860 | cites work | Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference | Q34207204 |
Oral polio vaccination of children in the tropics. II. Antibody response in relation to vaccine virus infection | Q39108539 | ||
Effect of breast-feeding on seroresponse of infants to oral poliovirus vaccination | Q39970102 | ||
Paralytic poliomyelitis: clinical and virological studies. | Q54105661 | ||
P433 | issue | 6013 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vaccine | Q134808 |
polio vaccine | Q1519099 | ||
P304 | page(s) | 812 | |
P577 | publication date | 1976-04-01 | |
1976-04-03 | |||
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Antibody response of infants in tropics to five doses of oral polio vaccine | |
P478 | volume | 1 |
Q50319723 | A better system for polio vaccination in developing countries? |
Q36147075 | A spatial model of Wild Poliovirus Type 1 in Kano State, Nigeria: calibration and assessment of elimination probability |
Q36675640 | Antibodies against poliomyelitis and measles viruses in immunized and unimmunized children, Ghana 1976-78. |
Q70909156 | Appropriate strategy for childhood immunization in India. II-The need and purpose of an authoritative immunization schedule |
Q36185607 | Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children |
Q47794110 | Causes of impaired oral vaccine efficacy in developing countries. |
Q91901469 | Chapter 4 Picornavirus infections |
Q36669805 | Clinical efficacy of trivalent oral poliomyelitis vaccine: a case-control study |
Q38594131 | Early immunization of neonates with trivalent oral poliovirus vaccine |
Q37425479 | Effect of human rotavirus vaccine on severe diarrhea in African infants |
Q73749881 | Effect of passively transferred anti-poliovirus antibodies on seroconversion |
Q40045569 | Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis |
Q38879736 | Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial |
Q24633576 | Eradicating poliomyelitis: India's journey from hyperendemic to polio-free status |
Q84955446 | Escape in four categories |
Q36799286 | Evaluation of a poliomyelitis immunization campaign in Madras city. |
Q37636873 | Evaluation of rotavirus vaccines in Asia--are there lessons to be learnt? |
Q30299958 | Exploring the role of environmental enteropathy in malnutrition, infant development and oral vaccine response |
Q37287347 | Factors determining anti-poliovirus type 3 antibodies among orally immunised Indian infants |
Q41879594 | Immune response of neonates to oral poliomyelitis vaccine. |
Q67450389 | Immunity level against poliomyelitis in a group of children vaccinated according to an official immunization schedule (São Paulo, Brazil) |
Q21245322 | Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine |
Q42201983 | Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants |
Q44772970 | Impact of annual immunisation programme with oral polio vaccine on the prevalence of paralytic poliomyelitis |
Q27024768 | Insights from global data for use of rotavirus vaccines in India |
Q61804344 | Interventions to improve oral vaccine performance: a systematic review and meta-analysis |
Q54204593 | Lymphoid tissue fibrosis is associated with impaired vaccine responses. |
Q33767570 | Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? |
Q99594866 | Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination |
Q44444464 | OPV cannot eradicate polio from India: do we need any further evidence? |
Q39815110 | Observations on Indian neurology. |
Q60920085 | Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies |
Q46989673 | Paralytic poliomyelitis: seasoned strategies, disappearing disease |
Q30301148 | Pediatric small intestine bacterial overgrowth in low-income countries |
Q44613483 | Polio eradication in India: some observations |
Q39342391 | Poliomyelitis outbreak in South Africa, 1982. II. Laboratory and vaccine aspects |
Q35923837 | Probiotics, antibiotics and the immune responses to vaccines. |
Q34324987 | Progress towards global polio eradication |
Q47832226 | Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030. |
Q37363974 | Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis |
Q36794380 | Randomized, controlled trial of trivalent oral poliovirus vaccine (sabin) starting at birth in Ghana |
Q68391999 | Revised immunisation schedule of the WHO expanded programme on immunisation |
Q81587066 | Role of genetic factors in polio eradication: new challenge for policy makers |
Q44901258 | Rotavirus vaccine: current status |
Q24595355 | The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergists |
Q36876170 | The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. |
Q39425504 | Vaccinology of poliomyelitis |
Q80655288 | What needs to be done for polio eradication in India? |
Q37493291 | Why polio has not been eradicated in India despite many remedial interventions? |
Search more.